Overview

A Study to Investigate the Effect of ACT-132577 on the Pharmacokinetics of Midazolam and 1-hydroxy Midazolam in Healthy Male Subjects

Status:
Completed

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of ACT-132577 on the pharmacokinetics of midazolam and 1-hydroxy midazolam and to evaluate the safety and tolerability of ACT-132577 when administered alone and in combination with midazolam.

Phase:

Phase 1

Details

Lead Sponsor:

Actelion
Idorsia Pharmaceuticals Ltd.

Treatments:

Midazolam